Christopher Heery's most recent trade in Arcellx Inc was a trade of 13,064 Common Stock done . Disclosure was reported to the exchange on Jan. 14, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jan 2026 | 13,064 | 43,199 | - | 0 | Common Stock | |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 68.51 per share. | 14 Jan 2026 | 5,882 | 23,749 | - | 68.5 | 402,997 | Common Stock |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jan 2026 | 16,520 | 30,135 | - | 0 | Common Stock | |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 65.51 per share. | 13 Jan 2026 | 7,437 | 29,631 | - | 65.5 | 487,213 | Common Stock |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2026 | 13,021 | 13,615 | - | 0 | Common Stock | |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 64.15 per share. | 12 Jan 2026 | 6,131 | 37,068 | - | 64.1 | 393,286 | Common Stock |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2026 | 67,708 | 67,708 | - | - | Restricted Stock Unit | |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jan 2026 | 16,520 | 30,135 | - | 0 | Common Stock | |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jan 2026 | 16,520 | 0 | - | - | Restricted Stock Unit | |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jan 2026 | 13,064 | 39,194 | - | - | Restricted Stock Unit | |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jan 2026 | 13,064 | 43,199 | - | 0 | Common Stock | |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jan 2026 | 13,021 | 13,615 | - | 0 | Common Stock | |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jan 2026 | 13,021 | 13,021 | - | - | Restricted Stock Unit | |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 90.00 per share. | 17 Nov 2025 | 340 | 284 | - | 90 | 30,600 | Common Stock |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 81.46 per share. | 30 Sep 2025 | 14,204 | 2,154 | - | 81.5 | 1,157,035 | Common Stock |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 80.55 per share. | 30 Sep 2025 | 5,300 | 16,358 | - | 80.6 | 426,925 | Common Stock |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 82.20 per share. | 30 Sep 2025 | 1,530 | 624 | - | 82.2 | 125,763 | Common Stock |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 80.16 per share. | 29 Sep 2025 | 73 | 21,658 | - | 80.2 | 5,852 | Common Stock |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 80.12 per share. | 26 Sep 2025 | 12,396 | 21,731 | - | 80.1 | 993,155 | Common Stock |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 80.01 per share. | 18 Sep 2025 | 3,343 | 34,427 | - | 80.0 | 267,468 | Common Stock |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 80.00 per share. | 18 Sep 2025 | 300 | 34,127 | - | 80 | 24,000 | Common Stock |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Feb 2025 | 22,556 | 47,641 | - | 0 | Common Stock | |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Feb 2025 | 22,556 | 0 | - | - | Restricted Stock Unit | |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 64.26 per share. | 24 Feb 2025 | 5,577 | 37,694 | - | 64.3 | 358,360 | Common Stock |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 63.14 per share. | 24 Feb 2025 | 4,370 | 43,271 | - | 63.1 | 275,918 | Common Stock |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 64.88 per share. | 24 Feb 2025 | 208 | 37,486 | - | 64.9 | 13,495 | Common Stock |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Feb 2025 | 22,556 | 47,641 | - | 0 | Common Stock | |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Feb 2025 | 22,556 | 0 | - | - | Restricted Stock Unit | |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 52,258 | 52,258 | - | - | Restricted Stock Unit | |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 52,258 | 52,258 | - | - | Restricted Stock Unit | |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jan 2025 | 16,519 | 38,818 | - | 0 | Common Stock | |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jan 2025 | 16,519 | 16,520 | - | - | Restricted Stock Unit | |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jan 2025 | 16,519 | 38,818 | - | 0 | Common Stock | |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jan 2025 | 16,519 | 16,520 | - | - | Restricted Stock Unit | |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jan 2025 | 13,021 | 22,299 | - | 0 | Common Stock | |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jan 2025 | 13,021 | 26,042 | - | - | Restricted Stock Unit | |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jan 2025 | 13,021 | 22,299 | - | 0 | Common Stock | |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jan 2025 | 13,021 | 26,042 | - | - | Restricted Stock Unit | |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 79.55 per share. | 02 Jan 2025 | 3,301 | 35,517 | - | 79.5 | 262,588 | Common Stock |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 79.55 per share. | 02 Jan 2025 | 3,301 | 35,517 | - | 79.5 | 262,588 | Common Stock |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 77.17 per share. | 02 Jan 2025 | 3,061 | 32,456 | - | 77.2 | 236,208 | Common Stock |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 77.17 per share. | 02 Jan 2025 | 3,061 | 32,456 | - | 77.2 | 236,208 | Common Stock |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Sep 2024 | 3,421 | 132,416 | - | - | Stock Option (right to buy) | |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 70.02 per share. | 05 Sep 2024 | 3,421 | 9,278 | - | 70.0 | 239,526 | Common Stock |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 15.00 per share. | 05 Sep 2024 | 3,421 | 12,699 | - | 15 | 51,315 | Common Stock |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 15.00 per share. | 03 Sep 2024 | 22,000 | 31,278 | - | 15 | 330,000 | Common Stock |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Sep 2024 | 22,000 | 135,837 | - | - | Stock Option (right to buy) | |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 66.05 per share. | 03 Sep 2024 | 14,776 | 21,953 | - | 66.0 | 975,912 | Common Stock |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 67.24 per share. | 03 Sep 2024 | 6,617 | 15,336 | - | 67.2 | 444,899 | Common Stock |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Sep 2024 | 5,451 | 43,604 | - | - | Stock Option (right to buy) | |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.28 per share. | 03 Sep 2024 | 5,451 | 36,729 | - | 6.3 | 34,232 | Common Stock |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 70.07 per share. | 03 Sep 2024 | 2,900 | 9,278 | - | 70.1 | 203,202 | Common Stock |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 68.01 per share. | 03 Sep 2024 | 1,958 | 13,378 | - | 68.0 | 133,168 | Common Stock |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 69.06 per share. | 03 Sep 2024 | 1,200 | 12,178 | - | 69.1 | 82,872 | Common Stock |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Aug 2024 | 21,684 | 157,837 | - | - | Stock Option (right to buy) | |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 15.00 per share. | 26 Aug 2024 | 21,684 | 30,962 | - | 15 | 325,260 | Common Stock |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 71.34 per share. | 26 Aug 2024 | 15,252 | 9,278 | - | 71.3 | 1,088,108 | Common Stock |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 70.61 per share. | 26 Aug 2024 | 6,432 | 24,530 | - | 70.6 | 454,165 | Common Stock |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 65.05 per share. | 16 Aug 2024 | 5,450 | 9,278 | - | 65.1 | 354,526 | Common Stock |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.28 per share. | 16 Aug 2024 | 5,450 | 14,728 | - | 6.3 | 34,226 | Common Stock |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Aug 2024 | 5,450 | 49,055 | - | - | Stock Option (right to buy) | |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 60.39 per share. | 01 Aug 2024 | 19,268 | 10,010 | - | 60.4 | 1,163,689 | Common Stock |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Aug 2024 | 10,684 | 179,521 | - | - | Stock Option (right to buy) | |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 15.00 per share. | 01 Aug 2024 | 10,684 | 29,278 | - | 15 | 160,260 | Common Stock |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.28 per share. | 01 Aug 2024 | 9,316 | 18,594 | - | 6.3 | 58,504 | Common Stock |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Aug 2024 | 9,316 | 54,505 | - | - | Stock Option (right to buy) | |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 61.13 per share. | 01 Aug 2024 | 732 | 9,278 | - | 61.1 | 44,746 | Common Stock |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 65.30 per share. | 16 Jul 2024 | 10,901 | 9,278 | - | 65.3 | 711,854 | Common Stock |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jul 2024 | 10,901 | 63,821 | - | - | Stock Option (right to buy) | |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.28 per share. | 16 Jul 2024 | 10,901 | 20,179 | - | 6.3 | 68,458 | Common Stock |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.28 per share. | 11 Jul 2024 | 3,671 | 12,949 | - | 6.3 | 23,054 | Common Stock |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Jul 2024 | 3,671 | 76,502 | - | - | Stock Option (right to buy) | |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 60.01 per share. | 11 Jul 2024 | 3,671 | 9,278 | - | 60.0 | 220,302 | Common Stock |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Jul 2024 | 1,780 | 74,722 | - | - | Stock Option (right to buy) | |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 60.21 per share. | 11 Jul 2024 | 1,780 | 9,278 | - | 60.2 | 107,175 | Common Stock |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.28 per share. | 11 Jul 2024 | 1,780 | 11,058 | - | 6.3 | 11,178 | Common Stock |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 55.26 per share. | 01 Jul 2024 | 17,217 | 12,061 | - | 55.3 | 951,372 | Common Stock |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 15.00 per share. | 01 Jul 2024 | 12,964 | 29,278 | - | 15 | 194,460 | Common Stock |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2024 | 12,964 | 190,205 | - | - | Stock Option (right to buy) | |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2024 | 7,036 | 80,173 | - | - | Stock Option (right to buy) | |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.28 per share. | 01 Jul 2024 | 7,036 | 16,314 | - | 6.3 | 44,186 | Common Stock |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 56.20 per share. | 01 Jul 2024 | 2,783 | 9,278 | - | 56.2 | 156,391 | Common Stock |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 55.13 per share. | 12 Jun 2024 | 19,918 | 9,360 | - | 55.1 | 1,098,073 | Common Stock |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jun 2024 | 12,036 | 203,169 | - | - | Stock Option (right to buy) | |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 15.00 per share. | 12 Jun 2024 | 12,036 | 29,278 | - | 15 | 180,540 | Common Stock |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.28 per share. | 12 Jun 2024 | 7,964 | 17,242 | - | 6.3 | 50,014 | Common Stock |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jun 2024 | 7,964 | 87,209 | - | - | Stock Option (right to buy) | |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 56.04 per share. | 12 Jun 2024 | 82 | 9,278 | - | 56.0 | 4,595 | Common Stock |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.28 per share. | 01 May 2024 | 18,168 | 27,106 | - | 6.3 | 114,095 | Common Stock |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 51.48 per share. | 01 May 2024 | 10,481 | 9,538 | - | 51.5 | 539,542 | Common Stock |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2024 | 10,000 | 95,173 | - | - | Stock Option (right to buy) | |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2024 | 8,168 | 10,901 | - | - | Stock Option (right to buy) | |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 50.99 per share. | 01 May 2024 | 7,087 | 20,019 | - | 51.0 | 361,346 | Common Stock |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 52.63 per share. | 01 May 2024 | 500 | 9,038 | - | 52.6 | 26,314 | Common Stock |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 53.55 per share. | 01 May 2024 | 100 | 8,938 | - | 53.6 | 5,355 | Common Stock |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 70.13 per share. | 22 Mar 2024 | 25,975 | 14,271 | - | 70.1 | 1,821,697 | Common Stock |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.28 per share. | 22 Mar 2024 | 20,000 | 50,303 | - | 6.3 | 125,600 | Common Stock |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 69.59 per share. | 22 Mar 2024 | 10,057 | 40,246 | - | 69.6 | 699,911 | Common Stock |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Mar 2024 | 10,000 | 19,069 | - | - | Stock Option (right to buy) | |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Mar 2024 | 10,000 | 110,623 | - | - | Stock Option (right to buy) | |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Mar 2024 | 5,450 | 105,173 | - | - | Stock Option (right to buy) |